Organ dysfunction in critically ill cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

Ahmed S and Oropello JM: Critical care issues in oncological surgery patients. Crit Care Clin. 26:93–106. 2010. View Article : Google Scholar

Cooksley TJ and Haji-Michael P: Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). World J Surg Oncol. 9:1692011. View Article : Google Scholar : PubMed/NCBI

Namendys-Silva SA, Texcocano-Becerra J and Herrera-Gómez A: Prognostic factors in critically ill patients with solid tumor admitted to an oncological intensive care unit. Anaesth Intensive Care. 38:317–324. 2010.PubMed/NCBI

López-Basave HN, Morales-Vásquez F, Ruiz Molina JM, et al: Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: national cancer institute, Mexico city, Mexico. ISRN Oncol. 2011:5263842011.PubMed/NCBI

Namendys-Silva SA, González-Herrera MO, García-Guillén FJ, Texcocano-Becerra J and Herrera-Gómez A: Outcome of critically ill patients with hematological malignancies. Ann Hematol. 92:699–705. 2013. View Article : Google Scholar : PubMed/NCBI

González-Moreno S, González-Bayón LA and Ortega-Pérez G: Hyperthermic intraperitoneal chemotherapy: Rationale and technique. World J Gastrointest Oncol. 2:68–75. 2010. View Article : Google Scholar : PubMed/NCBI

Dripps RD: New classification of physical status. Anesthesiol. 24:1111963.

Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 22:707–710. 1996. View Article : Google Scholar : PubMed/NCBI

Knaus WA, Draper EA, Wagner DP and Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med. 13:818–829. 1985. View Article : Google Scholar : PubMed/NCBI

Schmidt C, Moritz S, Rath S, Grossmann E, Wiesenack C, Piso P, Graf B and Bucher M: Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis. J Surg Oncol. 100:297–301. 2009. View Article : Google Scholar : PubMed/NCBI

Corcoran T, Rhodes JE, Clarke S, et al: Perioperative fluid management strategies in major surgery: a stratified meta-analysis. Anesth Analg. 114:640–651. 2012. View Article : Google Scholar : PubMed/NCBI

Raspe C, Piso P, Wiesenack C and Bucher M: Anesthetic management in patients undergoing hyperthermic chemotherapy. Curr Opin Anaesthesiol. 25:348–355. 2012. View Article : Google Scholar : PubMed/NCBI

Schmidt C, Creutzenberg M, Piso P, Hobbhahn J and Bucher M: Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia. 63:389–395. 2008. View Article : Google Scholar : PubMed/NCBI

Arakelian E, Gunningberg L, Larsson J, Norlén K and Mahteme H: Factors influencing early postoperative recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 37:897–903. 2011. View Article : Google Scholar : PubMed/NCBI

Rothfield KP and Crowley K: Anesthesia considerations during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Surg Oncol Clin N Am. 21:533–541. 2012. View Article : Google Scholar : PubMed/NCBI

Smeenk RM, Verwaal V and Zoetmulder FA: Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei - a report of 103 procedures. Eur J Surg Oncol. 32:186–190. 2006. View Article : Google Scholar

Murphy EM, Sexton R and Moran BJ: Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum. 50:37–42. 2007. View Article : Google Scholar